Surgery Partners (NASDAQ:SGRY – Free Report) had its price objective hoisted by JPMorgan Chase & Co. from $14.00 to $15.00 in a research report report published on Monday morning,Benzinga reports. They currently have a neutral rating on the stock. Several other research analysts have also recently weighed in on the stock. Benchmark reaffirmed a “buy” […]

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price target lifted by Morgan Stanley from $182.00 to $183.00 in a research report released on Friday,Benzinga reports. The firm currently has an equal weight rating on the stock. Several other brokerages have also recently issued reports on NBIX. Stifel Nicolaus raised their target price on Neurocrine […]

ODDITY Tech (NASDAQ:ODD – Free Report) had its price target upped by Truist Financial from $16.00 to $18.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a hold rating on the stock. ODD has been the subject of a number of other reports. Barclays decreased their price target on ODDITY […]

Paychex (NASDAQ:PAYX – Free Report) had its target price upped by Stifel Nicolaus from $110.00 to $130.00 in a report released on Wednesday morning,Benzinga reports. The brokerage currently has a hold rating on the business services provider’s stock. PAYX has been the subject of a number of other reports. Wells Fargo & Company increased their […]

Robinhood Markets (NASDAQ:HOOD – Get Free Report) had its price target hoisted by Cantor Fitzgerald from $115.00 to $150.00 in a report issued on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price would suggest a potential upside of 22.84% from the company’s current price. Several other […]